Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis

Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2013-12, Vol.8 (12), p.e85447
Hauptverfasser: Denkinger, Claudia M, Kalantri, Yatiraj, Schumacher, Samuel G, Michael, Joy S, Shankar, Deepa, Saxena, Arvind, Sriram, Natarajan, Balamugesh, Thangakunam, Luo, Robert, Pollock, Nira R, Pai, Madhukar, Christopher, Devasahayam J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 12
container_start_page e85447
container_title PloS one
container_volume 8
creator Denkinger, Claudia M
Kalantri, Yatiraj
Schumacher, Samuel G
Michael, Joy S
Shankar, Deepa
Saxena, Arvind
Sriram, Natarajan
Balamugesh, Thangakunam
Luo, Robert
Pollock, Nira R
Pai, Madhukar
Christopher, Devasahayam J
description Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300 pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000 pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1 out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis.
doi_str_mv 10.1371/journal.pone.0085447
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1470558623</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478148932</galeid><doaj_id>oai_doaj_org_article_76e79e1cb9794335aafea9c687182e4f</doaj_id><sourcerecordid>A478148932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-7c5b6273debfb3c62b7de1d9403ffa25aab1e9f34c0e558a491457df447be763</originalsourceid><addsrcrecordid>eNqNkl-L1DAUxYso7rr6DUQLguDDjE2TJu2LsAz-GVhY0MXXkKY3bZY0qUm66Lc343SXKShIH1puf-fc9PRk2UtUbBFm6P2tm70VZjs5C9uiqCtC2KPsHDW43NCywI9Pns-yZyHcFkWFa0qfZmclwYzWdXGezbtBGAO2h5Brm8cB8g7uwLhpBBtzp3Jhcz2Os3Vy8G4U0fVeTIOWCY_gFXhnN70YR5FHCDFXzuedFr11QYeDfjIwe2HyOLfg5WwO8-fZEyVMgBfL_SK7-fTxZvdlc3X9eb-7vNpI2pRxw2TV0pLhDlrVYknLlnWAuoYUWClRVkK0CBqFiSygqmpBGkQq1qmURAuM4ovs9dF2Slv5EljgiLAi4bTEidgfic6JWz55PQr_izuh-Z-B8z0XPmppgDMKrAEk24Y1BOO0XIFoJK0ZqksgKnl9WLbN7QidTPml716Zrt9YPfDe3XGcLGhZJoM3i4F3P-YU5j-OvFC9SKfSVrlkJkcdJL8krEakTn89Udu_UOnqYNQyVUbpNF8J3q0EiYnwM_ZiDoHvv339f_b6-5p9e8IOIEwcgjNz1M6GNUiOoPQuBA_qITlU8EPj79Pgh8bzpfFJ9uo09QfRfcXxbwBo_uk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1470558623</pqid></control><display><type>article</type><title>Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Denkinger, Claudia M ; Kalantri, Yatiraj ; Schumacher, Samuel G ; Michael, Joy S ; Shankar, Deepa ; Saxena, Arvind ; Sriram, Natarajan ; Balamugesh, Thangakunam ; Luo, Robert ; Pollock, Nira R ; Pai, Madhukar ; Christopher, Devasahayam J</creator><contributor>Goletti, Delia</contributor><creatorcontrib>Denkinger, Claudia M ; Kalantri, Yatiraj ; Schumacher, Samuel G ; Michael, Joy S ; Shankar, Deepa ; Saxena, Arvind ; Sriram, Natarajan ; Balamugesh, Thangakunam ; Luo, Robert ; Pollock, Nira R ; Pai, Madhukar ; Christopher, Devasahayam J ; Goletti, Delia</creatorcontrib><description>Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300 pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000 pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1 out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0085447</identifier><identifier>PMID: 24376880</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Accuracy ; Adenosine ; Adenosine deaminase ; Adolescent ; Adult ; Analysis ; Bioindicators ; Biological response modifiers ; Biomarkers ; Biomarkers - metabolism ; Biopsy ; Chromatography, Affinity - methods ; Cohort Studies ; Confidence intervals ; Consent ; Diagnosis ; Diagnostic systems ; Enzyme-Linked Immunosorbent Assay ; Enzymes ; Epidemiology ; Evaluation ; Female ; Freeze-thaw ; Freezing ; Freezing and thawing ; Humans ; Infectious diseases ; Interferon ; Interferon-gamma - metabolism ; Laboratories ; Male ; Medical diagnosis ; Medical tests ; Medicine ; Meta-analysis ; Middle Aged ; Occupational health ; Optimization ; Patients ; Pleural fluid ; Sensitivity ; Sensitivity and Specificity ; Studies ; Systematic review ; Thawing ; Tuberculosis ; Tuberculosis, Pleural - diagnosis ; Tuberculosis, Pleural - immunology</subject><ispartof>PloS one, 2013-12, Vol.8 (12), p.e85447</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 Denkinger et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2013 Denkinger et al 2013 Denkinger et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-7c5b6273debfb3c62b7de1d9403ffa25aab1e9f34c0e558a491457df447be763</citedby><cites>FETCH-LOGICAL-c692t-7c5b6273debfb3c62b7de1d9403ffa25aab1e9f34c0e558a491457df447be763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871622/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871622/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2095,2914,23846,27903,27904,53770,53772,79347,79348</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24376880$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Goletti, Delia</contributor><creatorcontrib>Denkinger, Claudia M</creatorcontrib><creatorcontrib>Kalantri, Yatiraj</creatorcontrib><creatorcontrib>Schumacher, Samuel G</creatorcontrib><creatorcontrib>Michael, Joy S</creatorcontrib><creatorcontrib>Shankar, Deepa</creatorcontrib><creatorcontrib>Saxena, Arvind</creatorcontrib><creatorcontrib>Sriram, Natarajan</creatorcontrib><creatorcontrib>Balamugesh, Thangakunam</creatorcontrib><creatorcontrib>Luo, Robert</creatorcontrib><creatorcontrib>Pollock, Nira R</creatorcontrib><creatorcontrib>Pai, Madhukar</creatorcontrib><creatorcontrib>Christopher, Devasahayam J</creatorcontrib><title>Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300 pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000 pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1 out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis.</description><subject>Accuracy</subject><subject>Adenosine</subject><subject>Adenosine deaminase</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Analysis</subject><subject>Bioindicators</subject><subject>Biological response modifiers</subject><subject>Biomarkers</subject><subject>Biomarkers - metabolism</subject><subject>Biopsy</subject><subject>Chromatography, Affinity - methods</subject><subject>Cohort Studies</subject><subject>Confidence intervals</subject><subject>Consent</subject><subject>Diagnosis</subject><subject>Diagnostic systems</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Enzymes</subject><subject>Epidemiology</subject><subject>Evaluation</subject><subject>Female</subject><subject>Freeze-thaw</subject><subject>Freezing</subject><subject>Freezing and thawing</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Interferon</subject><subject>Interferon-gamma - metabolism</subject><subject>Laboratories</subject><subject>Male</subject><subject>Medical diagnosis</subject><subject>Medical tests</subject><subject>Medicine</subject><subject>Meta-analysis</subject><subject>Middle Aged</subject><subject>Occupational health</subject><subject>Optimization</subject><subject>Patients</subject><subject>Pleural fluid</subject><subject>Sensitivity</subject><subject>Sensitivity and Specificity</subject><subject>Studies</subject><subject>Systematic review</subject><subject>Thawing</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Pleural - diagnosis</subject><subject>Tuberculosis, Pleural - immunology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl-L1DAUxYso7rr6DUQLguDDjE2TJu2LsAz-GVhY0MXXkKY3bZY0qUm66Lc343SXKShIH1puf-fc9PRk2UtUbBFm6P2tm70VZjs5C9uiqCtC2KPsHDW43NCywI9Pns-yZyHcFkWFa0qfZmclwYzWdXGezbtBGAO2h5Brm8cB8g7uwLhpBBtzp3Jhcz2Os3Vy8G4U0fVeTIOWCY_gFXhnN70YR5FHCDFXzuedFr11QYeDfjIwe2HyOLfg5WwO8-fZEyVMgBfL_SK7-fTxZvdlc3X9eb-7vNpI2pRxw2TV0pLhDlrVYknLlnWAuoYUWClRVkK0CBqFiSygqmpBGkQq1qmURAuM4ovs9dF2Slv5EljgiLAi4bTEidgfic6JWz55PQr_izuh-Z-B8z0XPmppgDMKrAEk24Y1BOO0XIFoJK0ZqksgKnl9WLbN7QidTPml716Zrt9YPfDe3XGcLGhZJoM3i4F3P-YU5j-OvFC9SKfSVrlkJkcdJL8krEakTn89Udu_UOnqYNQyVUbpNF8J3q0EiYnwM_ZiDoHvv339f_b6-5p9e8IOIEwcgjNz1M6GNUiOoPQuBA_qITlU8EPj79Pgh8bzpfFJ9uo09QfRfcXxbwBo_uk</recordid><startdate>20131223</startdate><enddate>20131223</enddate><creator>Denkinger, Claudia M</creator><creator>Kalantri, Yatiraj</creator><creator>Schumacher, Samuel G</creator><creator>Michael, Joy S</creator><creator>Shankar, Deepa</creator><creator>Saxena, Arvind</creator><creator>Sriram, Natarajan</creator><creator>Balamugesh, Thangakunam</creator><creator>Luo, Robert</creator><creator>Pollock, Nira R</creator><creator>Pai, Madhukar</creator><creator>Christopher, Devasahayam J</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20131223</creationdate><title>Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis</title><author>Denkinger, Claudia M ; Kalantri, Yatiraj ; Schumacher, Samuel G ; Michael, Joy S ; Shankar, Deepa ; Saxena, Arvind ; Sriram, Natarajan ; Balamugesh, Thangakunam ; Luo, Robert ; Pollock, Nira R ; Pai, Madhukar ; Christopher, Devasahayam J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-7c5b6273debfb3c62b7de1d9403ffa25aab1e9f34c0e558a491457df447be763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Accuracy</topic><topic>Adenosine</topic><topic>Adenosine deaminase</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Analysis</topic><topic>Bioindicators</topic><topic>Biological response modifiers</topic><topic>Biomarkers</topic><topic>Biomarkers - metabolism</topic><topic>Biopsy</topic><topic>Chromatography, Affinity - methods</topic><topic>Cohort Studies</topic><topic>Confidence intervals</topic><topic>Consent</topic><topic>Diagnosis</topic><topic>Diagnostic systems</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Enzymes</topic><topic>Epidemiology</topic><topic>Evaluation</topic><topic>Female</topic><topic>Freeze-thaw</topic><topic>Freezing</topic><topic>Freezing and thawing</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Interferon</topic><topic>Interferon-gamma - metabolism</topic><topic>Laboratories</topic><topic>Male</topic><topic>Medical diagnosis</topic><topic>Medical tests</topic><topic>Medicine</topic><topic>Meta-analysis</topic><topic>Middle Aged</topic><topic>Occupational health</topic><topic>Optimization</topic><topic>Patients</topic><topic>Pleural fluid</topic><topic>Sensitivity</topic><topic>Sensitivity and Specificity</topic><topic>Studies</topic><topic>Systematic review</topic><topic>Thawing</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Pleural - diagnosis</topic><topic>Tuberculosis, Pleural - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Denkinger, Claudia M</creatorcontrib><creatorcontrib>Kalantri, Yatiraj</creatorcontrib><creatorcontrib>Schumacher, Samuel G</creatorcontrib><creatorcontrib>Michael, Joy S</creatorcontrib><creatorcontrib>Shankar, Deepa</creatorcontrib><creatorcontrib>Saxena, Arvind</creatorcontrib><creatorcontrib>Sriram, Natarajan</creatorcontrib><creatorcontrib>Balamugesh, Thangakunam</creatorcontrib><creatorcontrib>Luo, Robert</creatorcontrib><creatorcontrib>Pollock, Nira R</creatorcontrib><creatorcontrib>Pai, Madhukar</creatorcontrib><creatorcontrib>Christopher, Devasahayam J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Denkinger, Claudia M</au><au>Kalantri, Yatiraj</au><au>Schumacher, Samuel G</au><au>Michael, Joy S</au><au>Shankar, Deepa</au><au>Saxena, Arvind</au><au>Sriram, Natarajan</au><au>Balamugesh, Thangakunam</au><au>Luo, Robert</au><au>Pollock, Nira R</au><au>Pai, Madhukar</au><au>Christopher, Devasahayam J</au><au>Goletti, Delia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-12-23</date><risdate>2013</risdate><volume>8</volume><issue>12</issue><spage>e85447</spage><pages>e85447-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Existing diagnostic tests for pleural tuberculosis (TB) have inadequate accuracy and/or turnaround time. Interferon-gamma (IFNg) has been identified in many studies as a biomarker for pleural TB. Our objective was to develop a lateral flow, immunochromatographic test (ICT) based on this biomarker and to evaluate the test in a clinical cohort. Because IFNg is commonly present in non-TB pleural effusions in low amounts, a diagnostic IFNg-threshold was first defined with an enzyme-linked immunosorbent assay (ELISA) for IFNg in samples from 38 patients with a confirmed clinical diagnosis (cut-off of 300 pg/ml; 94% sensitivity and 93% specificity). The ICT was then designed; however, its achievable limit of detection (5000 pg/ml) was over 10-fold higher than that of the ELISA. After several iterations in development, the prototype ICT assay for IFNg had a sensitivity of 69% (95% confidence interval (CI): 50-83) and a specificity of 94% (95% CI: 81-99%) compared to ELISA on frozen samples. Evaluation of the prototype in a prospective clinical cohort (72 patients) on fresh pleural fluid samples, in comparison to a composite reference standard (including histopathological and microbiologic test results), showed that the prototype had 65% sensitivity (95% CI: 44-83) and 89% specificity (95% CI: 74-97). Discordant results were observed in 15% of samples if testing was repeated after one freezing and thawing step. Inter-rater variability was limited (3%; 1 out of 32). In conclusion, despite an iterative development and optimization process, the performance of the IFNg ICT remained lower than what could be expected from the published literature on IFNg as a biomarker in pleural fluid. Further improvements in the limit of detection of an ICT for IFNg, and possibly combination of IFNg with other biomarkers such as adenosine deaminase, are necessary for such a test to be of value in the evaluation of pleural tuberculosis.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>24376880</pmid><doi>10.1371/journal.pone.0085447</doi><tpages>e85447</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2013-12, Vol.8 (12), p.e85447
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1470558623
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Accuracy
Adenosine
Adenosine deaminase
Adolescent
Adult
Analysis
Bioindicators
Biological response modifiers
Biomarkers
Biomarkers - metabolism
Biopsy
Chromatography, Affinity - methods
Cohort Studies
Confidence intervals
Consent
Diagnosis
Diagnostic systems
Enzyme-Linked Immunosorbent Assay
Enzymes
Epidemiology
Evaluation
Female
Freeze-thaw
Freezing
Freezing and thawing
Humans
Infectious diseases
Interferon
Interferon-gamma - metabolism
Laboratories
Male
Medical diagnosis
Medical tests
Medicine
Meta-analysis
Middle Aged
Occupational health
Optimization
Patients
Pleural fluid
Sensitivity
Sensitivity and Specificity
Studies
Systematic review
Thawing
Tuberculosis
Tuberculosis, Pleural - diagnosis
Tuberculosis, Pleural - immunology
title Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T02%3A16%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Challenges%20in%20the%20development%20of%20an%20immunochromatographic%20interferon-gamma%20test%20for%20diagnosis%20of%20pleural%20tuberculosis&rft.jtitle=PloS%20one&rft.au=Denkinger,%20Claudia%20M&rft.date=2013-12-23&rft.volume=8&rft.issue=12&rft.spage=e85447&rft.pages=e85447-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0085447&rft_dat=%3Cgale_plos_%3EA478148932%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1470558623&rft_id=info:pmid/24376880&rft_galeid=A478148932&rft_doaj_id=oai_doaj_org_article_76e79e1cb9794335aafea9c687182e4f&rfr_iscdi=true